Sarissa Capital Management as of Sept. 30, 2014
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 14 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ariad Pharmaceuticals | 26.8 | $69M | 13M | 5.40 | |
| Quest Diagnostics Incorporated (DGX) | 18.2 | $47M | 775k | 60.68 | |
| Bio-reference Labs Com $.01 New | 13.9 | $36M | 1.3M | 28.06 | |
| Agilent Technologies Inc C ommon (A) | 10.1 | $26M | 460k | 56.98 | |
| Merck & Co (MRK) | 9.2 | $24M | 400k | 59.28 | |
| Amgen (AMGN) | 6.5 | $17M | 120k | 140.46 | |
| Repros Therapeutics Com New | 4.3 | $11M | 1.1M | 9.90 | |
| Vivus | 3.8 | $9.9M | 2.6M | 3.86 | |
| Intra Cellular Therapies (ITCI) | 1.9 | $4.9M | 360k | 13.71 | |
| Enanta Pharmaceuticals (ENTA) | 1.6 | $4.2M | 105k | 39.57 | |
| Kindred Biosciences | 1.4 | $3.6M | 390k | 9.25 | |
| AVEO Pharmaceuticals | 1.1 | $2.9M | 2.6M | 1.11 | |
| Targacept | 0.6 | $1.6M | 630k | 2.53 | |
| Onconova Therapeutics | 0.6 | $1.5M | 350k | 4.30 |
